Back
Dyne Therapeutics 10K Form
Sell
42
DYN
Dyne Therapeutics
Last Price:
28.04
Seasonality Move:
27.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DYN News And Ratings
See the #1 stock for the next 7 days that we like better than DYN
DYN Financial Statistics
Sales & Book Value
Annual Sales: | $4.84B |
---|---|
Cash Flow: | $-74.88M |
Price / Cash Flow: | 0 |
Annual Sales: | $6.93 |
Price / Book: | 4.22 |
Profitability
EPS (TTM): | -3.56000 |
---|---|
Net Income (TTM): | $-294.51M |
Gross Margin: | $1.91B |
Return on Equity: | 0% |
Return on Assets: | 0% |
Dyne Therapeutics Earnings Forecast
Key Dyne Therapeutics Financial Ratios
Dyne Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | DYN |
CUSIP: | 26818M |
Website: | dyne-tx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DYN Technical Analysis vs Fundamental Analysis
Sell
42
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy or a Sell?
-
Dyne Therapeutics stock is rated a Sell
The current Dyne Therapeutics [DYN] share price is $29.28. The Score for DYN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.